Valens can now ship products to five provinces and one territory in

Canada

KELOWNA, BC

,

April 21, 2021

/PRNewswire/ –


The Valens Company Inc.


(TSX: VLNS) (OTCQX: VLNCF) (the

“Company,”


“The Valens Company”

or

“Valens”

),


a leading manufacturer of cannabis products, today announced its entry into the

Yukon

market with a cannabis purchase and sale agreement with the Yukon Liquor Corporation (YLC).

The agreement allows for the sale and distribution of Valens-manufactured products to licensed cannabis retailers in

Yukon

and on


Cannabis

Yukon



, Yukon Liquor Corporation’s ecommerce platform. Valens expects to bring a range of Cannabis 2.0 and 3.0 products to the

Yukon

market, which could include vapes, concentrates, beverages, topicals and edibles, expanding the variety of innovative formats available in the territory.

“Our entry into the

Yukon

market not only furthers our ability to capture market share in

Canada

, but also broadens the selection and quality of products that consumers in the territory can access,” said

Tyler Robson

, CEO, Co-Founder and Chair of The Valens Company. “We have made significant progress growing our cannabis distribution network and we expect to increase our national position in the short-term as we continue discussions with other private and government-regulated retailers across the country.”

Valens-manufactured products will be shipped to

Yukon

and available to consumers in the coming quarters.

At Valens, it’s Personal.

About The Valens Company


The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. The Company provides proprietary cannabis processing services across five core technologies, in addition to best-in-class product development, formulation and manufacturing of cannabis consumer packaged goods. The Valens Company’s high-quality products are exclusively formulated for the medical, therapeutic, health and wellness, and recreational consumer segments, and are offered across numerous product formats, including oils, vapes, concentrates, edibles and topicals, as well as pre-rolls, with a focus on next-generation product development and innovation. Its breakthrough patented emulsification technology, SōRSE™ by Valens, converts cannabis oil into water-soluble emulsions for seamless integration into a variety of product formats, allowing for near-perfect dosing, stability, and taste. In partnership with brand houses, consumer packaged goods companies and licensed cannabis producers around the globe, the Company continues to grow its diverse product portfolio in alignment with evolving cannabis consumer preferences in key markets. Through its wholly owned subsidiary Valens Labs Ltd., the Company is setting the standard in cannabis testing and research and development with

Canada’s

only ISO17025 accredited analytical services lab, named The Centre of Excellence in Plant-Based Science by partner and scientific world leader Thermo Fisher Scientific. Discover more on The Valens Company and its subsidiaries at

.

Notice regarding Forward Looking Statements


All information included in this press release, including any information as to the future financial or operating performance and other statements of The Valens Company that express management’s expectations or estimates of future performance, other than statements of historical fact, constitute forward-looking information or forward-looking statements within the meaning of applicable securities laws and are based on expectations, estimates and projections as of the date hereof. Forward-looking statements are included for the purpose of providing information about management’s current expectations and plans relating to the future. Wherever possible, words such as “plans”, “expects”, “scheduled”, “trends”, “forecasts”, “future”, “indications”, “potential”, “estimates”, “predicts”, “anticipate”, “to establish”, “believe”, “intend”, “ability to”, or statements that certain actions, events or results “may”, “should”, “could”, “would”, “might”, “will”, or are “likely” to be taken, occur or be achieved, or the negative of these words or other variations thereof, have been used to identify such forward-looking information. Specific forward-looking statements include, without limitation, all disclosure regarding future results of operations, future outcomes of transactions, economic conditions, and anticipated courses of action. Investors and other parties are advised that there is not necessarily any correlation between the number of SKUs manufactured and shipped and revenue and profit, and undue reliance should not be placed on such information.

The risks and uncertainties that may affect forward-looking statements include, among others,  Canadian regulatory risk, Australian regulatory risk, U.S. regulatory risk, U.S. border crossing and travel bans, the uncertainties, effects of and responses to the COVID-19 pandemic, reliance on licenses, expansion of facilities, competition, dependence on supply of cannabis and reliance on other key inputs, dependence on senior management and key personnel, general business risk and liability, regulation of the cannabis industry, change in laws, regulations and guidelines, compliance with laws, limited operating history, vulnerability to rising energy costs, unfavourable publicity or consumer perception, product liability, risks related to intellectual property, product recalls, difficulties with forecasts, management of growth and litigation, many of which are beyond the control of The Valens Company. For a more comprehensive discussion of the risks faced by The Valens Company, and which may cause the actual financial results, performance or achievements of The Valens Company to be materially different from estimated future results, performance or achievements expressed or implied by forward-looking information or forward-looking statements, please refer to The Valens Company’s latest Annual Information Form filed with Canadian securities regulatory authorities at

www.sedar.com

or on The Valens Company’s website at

www.thevalenscompany.com

. The risks described in such Annual Information Form are hereby incorporated by reference herein. Although the forward-looking statements contained herein reflect management’s current beliefs and reasonable assumptions based upon information available to management as of the date hereof, The Valens Company cannot be certain that actual results will be consistent with such forward-looking information. The Valens Company cautions you not to place undue reliance upon any such forward-looking statements. The Valens Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

View original content to download multimedia:

http://www.prnewswire.com/news-releases/the-valens-company-increases-domestic-reach-with-distribution-agreement-with-yukon-territory-301274267.html

SOURCE The Valens Company Inc.